Skip to main content
Premium Trial:

Request an Annual Quote

J&Jer Moves to Caliper as Diagnostic Diva


The new vice president at Caliper Technologies is having her cake and eating it too.

Susan Evans, who took up the reins of VP of product development, wears two hats: one of manager, and the other, scientist.

“One of the nice things about being at Caliper is that I get to do both,” Evans says. “That’s one of the advantages about being in a smaller company that has such a strong science and technology foundation. In the end you’re not only managing the business aspects but the technical side too.”

Evans brings to the seven-year-old, Mountain View, Calif.-based company experience from LifeScan, a Johnson & Johnson company, where she was vice president of R&D; she also worked at clinical diagnostic firm Dade Behring as a senior veep.

Despite 20 years of research and product development in the medical diagnostic industry, Evans was lured to Caliper by its palm-sized chips. “It’s an exciting new technology,” she says. “It’s a technology that not only has the potential of applications in the research market and high-throughput screening market, but also in clinical diagnostics.”

She believes her in-depth understanding of the diagnostics market could usher Caliper’s technology into that field, where higher throughput, miniaturization, efficiency, accuracy, and quality are vital.

— Jasmin Chua

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.